GUANFACINE TREATMENT OF COMORBID ATTENTION-DEFICIT HYPERACTIVITY DISORDER AND TOURETTE'S SYNDROME: PRELIMINARY CLINICAL EXPERIENCE
Gardado en:
CHAPPELL, P.B., ET AL., GUANFACINE TREATMENT OF COMORBID ATTENTION-DEFICIT HYPERACTIVITY DISORDER AND TOURETTE'S SYNDROME: PRELIMINARY CLINICAL EXPERIENCE. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, Vol. 34, no. 9 (1995), p. 1140-1146.
Ref.
49185
Localización:
SIIS SIIS Madrid R.598
Palabras clave:
Enfermedades mentales, Fármacos, Hiperactividad, Infancia, Trastornos de atención, Tratamiento
Enfermedades mentales, Fármacos, Hiperactividad, Infancia, Trastornos de atención, Tratamiento
Títulos similares: GUANFACINE TREATMENT OF COMORBID ATTENTION-DEFICIT HYPERACTIVITY DISORDER AND TOURETTE'S SYNDROME: PRELIMINARY CLINICAL EXPERIENCE
- AN OPEN TRIAL OF GUANFACINE IN THE TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER
- METHYLPHENIDATE TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER IN BOYS WITH TOURETTE'S SYNDROME
- DESIPRAMINE TREATMENT OF CHILDREN WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER AND TIC DISORDER OR TOURETTE'S SYNDROME
- DESIPRAMINE TREATMENT OF BOYS WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDERAND TICS: PRELIMINARY CLINICAL EXPERIENCE
- COMORBIDITY OF CENTRAL AUDITORY PROCESSING DISORDER AND ATTENTION-DEFICIT HYPERACTIVITY DISORDER
- IMPACT OF COMORBID OPPOSITIONAL OR CONDUCT PROBLEMS ON ATTENTION-DEFICIT HYPERACTIVITY DISORDER